• PHP48 Os Motivos Que Levam O JudiciÁrio A Determinar Que Os Planos De SaÚde ForneÇam MedicaÇÃo oral Em Oncologia

    Nov 1, 2011, 00:00

  • PND35 Belgian Cost-Utility Analysis of Gilenya® (Fingolimod) in the Management of Adults with Active Relapsing Remitting Multiple Sclerosis

    Nov 1, 2011, 00:00

  • PCN152 Can Breast Cancer Risk Prediction Reduce the Risks of False Negative and False Positive Screening Mammograms?

    Nov 1, 2011, 00:00

  • PSS29 Treatment Patterns of Psoriasis Patients and Trends Over Time

    Nov 1, 2011, 00:00

  • PSY15 Striving for Affordable Treatments Within the Greek Environment- Do Epoetin Biosimilars Help?

    Nov 1, 2011, 00:00

  • PIH56 Performance Assessment of Ga District Mutual Health Insurance Scheme in the Greater Accra Region in Ghana

    Nov 1, 2011, 00:00

  • PDB48 SHORT-Term Cost-Effectiveness of Insulin Detemir Versus NPH Insulin in Insulin-Naïve Subjects with Type 2 Diabetes in Sweden

    Nov 1, 2011, 00:00

  • PCN127 Health State Utility Assessment for Breast Cancer

    Nov 1, 2011, 00:00

  • PHP38 Market Access for Pharmaceuticals in UK- Number and Speed of Drug Reviews to Improve After Introduction of Value Based Pricing

    Nov 1, 2011, 00:00

  • PSS17 Societal Burden of Blindness in Hungary

    Nov 1, 2011, 00:00

  • PUK7 3 Years Follow Up of the Pharmacotherapy Cost of Patients with Kidney Transplantation in Bulgaria

    Nov 1, 2011, 00:00

  • PRS3 The Effect Of Aat Replacement Therapy on Patient Length And Quality Of Life - a Markov Model

    Nov 1, 2011, 00:00

  • PMS70 Evaluation of Prescribed Pain Medications Prior to the Initiation of Duloxetine Therapy in a Commercially Insured Population

    Nov 1, 2011, 00:00

  • PRS68 A Systematic Review of Chronic Rhinosinusitis in Asia-Pacfic and the Role of Balloon Sinuplasty

    Nov 1, 2011, 00:00

  • PMS12 Evaluacion Economica De Rituximab versus anti-Tnf En Pacientes Con Artritis reumatoide Y Falla Previa A anti-Tnf En México

    Nov 1, 2011, 00:00

  • PRM55 A New Approach to Modeling Cancer Recurrence and Follow-Up

    Nov 1, 2011, 00:00

  • ISPOR 3rd Latin America conference disclosure information for reserch presentations

    Nov 1, 2011, 00:00

  • PMS28 Retrospective Chart Review to Assess Utilization of Resources and Costs Related to Postmenopausal Osteoporotic Fractures in Slovenia, Serbia and Bulgaria

    Nov 1, 2011, 00:00

  • PRS25 Systematic Literature Review of Economic and Humanistic Burden of Dyspnoea in COPD

    Nov 1, 2011, 00:00

  • PMH78 Retrospective Prescription Analysis of Dementia in a South Indian Psychiatric Hopital

    Nov 1, 2011, 00:00

  • PRM66 Comparison of Reconciliation and Review Methodologies for the Translation of Patient Reported Outcome (PRO) Measures

    Nov 1, 2011, 00:00

  • PCN185 A Multi-Country Retrospective Study of Patient Characteristics and Treatment Patterns in Chronic Myeloid Leukemia

    Nov 1, 2011, 00:00

  • PMD12 Economic Impact analysis of Sterilization of Rigid Endoscopes with Sterradtm versus Steam in Spain

    Nov 1, 2011, 00:00

  • PRS20 Costs of COPD By Disease Severity - a Comparison Over 10 Years

    Nov 1, 2011, 00:00

  • PIN100 Why Don't Health Practitioners Prescribe Rationally in Malaria? A qualitative Study from Pakistan

    Nov 1, 2011, 00:00

  • Copyright/Subscription

    Nov 1, 2011, 00:00

  • PCN5 Efectividad CLÍnica Y Costo-Efectividad Del Tratamiento De Segunda LÍnea Para Carcinoma MetastÁsico De CÉlulas Renales

    Nov 1, 2011, 00:00

  • PCV10 Un Estudio De Minimizacion De Costos Para Evaluar El Tratamiento Con Metoprolol En Pacientes Con Hipertension Arterial En México

    Nov 1, 2011, 00:00

  • PIN31 Quantifying the Financial and Disease Burden Associated with Mother to Child Transmission of HIV in Uganda

    Nov 1, 2011, 00:00

  • PMS77 Improving Quality and Reducing Costs in Workers' Compensation Health Care- A Population-Based Intervention Study

    Nov 1, 2011, 00:00

  • PND42 Impact of Relapses Leading to Hospitalisation on Health-Related Quality of Life, Fatigue and Health Care Resource Utilisation in A Population with A Relapsing Form of Multiple Sclerosis (RMS) Using Data from Temso A Teriflunonomide Pi ...

    Nov 1, 2011, 00:00

  • PMD14 Budget Impact analysis of Two Drug-Eluting Stents for Diabetic Patients in Spain

    Nov 1, 2011, 00:00

  • PRM6 Translation of Patient-Reported Outcomes Measures Translatability Review And Item Definition

    Nov 1, 2011, 00:00

  • PND1 Estimating Net Health Benefits Of Intramuscular Interferon Beta-1A And Fingolimod In Treating Patients With Relapsing-Remitting Multiple Sclerosis

    Nov 1, 2011, 00:00

  • PIN68 Cost- Effectiveness Analysis of Human Papillomavirus Vaccination Program in Russia

    Nov 1, 2011, 00:00

  • PRM51 Nonparametric Regression Analysis Controls Cost Analysis in Data with Outliers

    Nov 1, 2011, 00:00

  • PRS60 The Impact of Severe Poor-Controlled Asthma On Patients' Quality of Life Control Study

    Nov 1, 2011, 00:00

  • PND9 The Role of Spontaneous Events Databases for Benefit-Risk Analysis

    Nov 1, 2011, 00:00

  • MT4 Mixed Treatment Comparisons Using Aggregate- and individual-Participant Level Data- An Efficient Use of Evidence for Cost-Effectiveness Modelling

    Nov 1, 2011, 00:00

  • PMD37 Cost-Effectiveness of the Ex-Press Glaucoma Filtration Device in France

    Nov 1, 2011, 00:00

  • PHP9 Preditores Da quantidade De Medicamentos Tomados Em Pessoas Com DoenÇa Crónica

    Nov 1, 2011, 00:00

  • PDB68 The Impact of Implementing a Drug Preauthorization Policy in a Primary Care Setting

    Nov 1, 2011, 00:00

  • PMD71 Resource Use Caused by in-office Follow-up Visits for Cardiac Implantable Electrical Devices (CIED) in Germany and the United Kingdom

    Nov 1, 2011, 00:00

  • PMH83 Estimating Utilities in Schizophrenic and Bipolar Patients from Disease-Specific or Generic Instruments Assessing Patients' Health States- Where are the Differences?

    Nov 1, 2011, 00:00

  • PDB42 Economic Evaluation of Recombinant Human FSH in Comparison with Urinary HMG in Assisted Reproduction in the Greek Setting

    Nov 1, 2011, 00:00

  • PSY9 Evaluación Económica De Dieta Inmunoreguladora (Inmunex Plus®) En Pacientes Mexicanos

    Nov 1, 2011, 00:00

  • PMH56 Negative Symptoms Have Greater Impact on Functioning Than Positive Symptoms in Schizophrenia- Analysis of Catie Data

    Nov 1, 2011, 00:00

  • PCV34 Improving Global Vascular Risk Management (GVRM) Using the COSEHC Cardiovascular Risk Assessment Tool

    Nov 1, 2011, 00:00

  • PMH71 The Impact of Once-Daily Extended-Release Quetiapine Fumarate (Quetiapine XR) on Length and Costs of Hospitalisation of Patients with Schizophrenia or Bipolar Disorder

    Nov 1, 2011, 00:00

  • PDB83 The Epidemiology and Burden of Obesity and Diabetes in Fran A Methodological Comparison

    Nov 1, 2011, 00:00

  • PMD30 Cost-Effectiveness Analysis of Pulmonary Vein Isolation (PVI) Using A Novel Cryo Energy-Based Balloon Catheter- A High-Value procedure for Payers?

    Nov 1, 2011, 00:00

  • PMD13 Cost Analysis of Vascular Closure Devices (VCD) in the United States

    Nov 1, 2011, 00:00

  • PRM30 A Comparison of the Patientslikeme Quality of Life Questionnaire (PLMQOL) with the Rand SF-36

    Nov 1, 2011, 00:00

  • PIH44 Health-Related Quality of Life for Patients with Chronic Conditions- Revealing the Profile of Burden Associated with Co-Morbid Physical and Mental Conditions in Respondents from Five European Countries

    Nov 1, 2011, 00:00

  • PMS61 Rapid Reductions in Fatigue and Sleep Problems and Correlation with Improvements in Patient-Reported Outcomes in Patients with Active RA Treated with Certolizumab Pegol in the realistic 12-Week Phase IIIB Randomised Controlled Study

    Nov 1, 2011, 00:00

  • PND46 The Huntington Quality of Life Instrument (H-QOL-I)- Cross-Cultural Validation in Germany, Poland and USA

    Nov 1, 2011, 00:00

  • PGI25 Chronic Hepatitis C (CHC) Related Flu-like Symptoms; Development of a Patient Report Outcome (PRO) Measure and Results from Pilot Efficacy Studies

    Nov 1, 2011, 00:00

  • PCV82 Simulation of Long-Term Clinical Benefits and Costs of Add-On Therapy with Aliskiren in Hypertensive Patients with Diabetic Nephropathy- A German Statutory Health Insurance Perspective

    Nov 1, 2011, 00:00

  • PCV32 Population Attributable Risk (PAR) of Macrovascular Events Associated with HbA1C, Blood Pressure or Weight in Patients with Type 2 Diabetes Mellitus- Evidence from a Dutch Cohort

    Nov 1, 2011, 00:00

  • PND22 A Cost-of-Illness Analysis of Myasthenia Gravis in Greece

    Nov 1, 2011, 00:00

  • PGI2 Cost-Effectiveness Analysis of the Use of Adalimumab for the Treatment of Crohn's Disease (CD) in Mexico

    Nov 1, 2011, 00:00

  • PND18 Recent Trends in Muscular Dystrophy-Related Inpatient Care Among Pediatric Patients In The United States

    Nov 1, 2011, 00:00

  • PRM15 The Outcome of ISPOR European and International Congresses Between 2005-2009

    Nov 1, 2011, 00:00

  • PMS7 The Osteoporotic Fracture Incidence in Elderly Women of Taiwan

    Nov 1, 2011, 00:00

  • PIH40 Designing a Disease-Specific Patient Reported Outcome (PRO) for a Rare Disease- Assessing the Reliability, Validity, and Responsiveness of the Hunter Syndrome - Functional Outcomes for Clinical Understanding Scale (HS-Focus)

    Nov 1, 2011, 00:00

  • PCN163 Funding by SHAs for Rarer Cancers in England- Key Success Factors in the Uptake of Cancer Drugs Fund

    Nov 1, 2011, 00:00

  • PHP125 Clinical Trial Learning Curves May Impact Both Clinical and Economic Outcomes, and Influence Health Technology Assessment and Reimbursement Decision Making

    Nov 1, 2011, 00:00

  • PND28 Cost-Effectiveness Analysis of Interferons and Glatiramer Acetate as First Line Treatments in Remitting – Relapsing Multiple Sclerosis Spanish Patients

    Nov 1, 2011, 00:00

  • PSS35 Validation of the Eighteen Item Functional Assessment of Visual Tasks (Vistas-18) Using A New Lens Prescription Methodology

    Nov 1, 2011, 00:00

  • PHP45 Predictability of Pharmaceutical Spending Using Clinical Risk Groups in the Valencian Community in Valencia

    Nov 1, 2011, 00:00

  • PCN85 Cost-Effectiveness of A Human Papillomavirus Vaccination of Boys

    Nov 1, 2011, 00:00

  • PHP1 Improving Patient Safety in the UK and Engaging Patients in research- A New Model for the NHS?

    Nov 1, 2011, 00:00

  • PIN66 Cost of Virologic Failure with Etravirine and Raltegravir in the Brazilian National AIDS Program

    Nov 1, 2011, 00:00

  • PHP11 Fact or Fallacy- Does Medical Technology Drive Health Care Spending?

    Nov 1, 2011, 00:00

  • PRM34 Examining Variations in Item Structure and Content in Pro Instruments, or, There Must be 50 Ways to Express Your Distress

    Nov 1, 2011, 00:00

  • PSY35 Economic Evaluation of Darbepoetin Alfa in the Management of End Stage Renal Disease (ESRD) Patients with Anemia in the Greek Nhs Setting

    Nov 1, 2011, 00:00

  • PRS5 Analysis Of Efficacy and Safety of Dornase Alfa in The Treatment of Cystic Fibrosis

    Nov 1, 2011, 00:00

  • PIH16 analyzing the Adverse Drug reactions of Geriatric Population at A regional Academic Hospital of southern Taiwan

    Nov 1, 2011, 00:00

  • PSY13 Comparing Top Reasons for Primary Care or Specialty Care Visits Among Fibromyalgia Patients Initiated Duloxetine Versus Pregabalin

    Nov 1, 2011, 00:00

  • PDB73 Impact of Epidemiological and Economic Factors on Insulin Total Sales in the UK Diabetic Market

    Nov 1, 2011, 00:00

  • PIH3 Respiratory Syncytial Virus Hospitalizations in the Canadian Registry for Synagis (CARESS)

    Nov 1, 2011, 00:00

  • PSU6 Long Term Effectiveness of Limbal Relaxing Incision (LRI) During Cataract Surgery to Correct Astigmatism

    Nov 1, 2011, 00:00

  • PCN105 Economic Evaluation of Panitumumab and Cetuximab in the Treatment of Patients with EGFR Expressing mCRC with Non-Mutated (Wild-Type) KRAS in Gree A Cost Minimization Analysis

    Nov 1, 2011, 00:00

  • PDB7 Prevalence, Demographics and Treatment Characteristics of Diabetes with Lantus, NPH and Premix Insulin in a Representative Canadian Cohort

    Nov 1, 2011, 00:00

  • PMH24 Economic Burden of Mental Illnesses in Pakistan

    Nov 1, 2011, 00:00

  • PSS46 Availability of Resources for Patients With Wet Age-Related Macular Degeneration- Optimal Study

    Nov 1, 2011, 00:00

  • PMH43 Association Between Antidepressant-Related Weight Gain and Medication Adherence in Employed Individuals by Gender

    Nov 1, 2011, 00:00

  • PCV21 Clinical Efficacy of Bisoprolol Compared to Atenolol in Reducing the In-Clinic and Ambulatory Blood Pressure in Hypertensive Patients

    Nov 1, 2011, 00:00

  • PRM24 Scan- An Integrated System for Market Access of New Drugs in Italy

    Nov 1, 2011, 00:00

  • PSY25 What is the Economic Impact of Obesity on Hospital Inpatient Care?

    Nov 1, 2011, 00:00

  • PIN29 Linezolid Versus Vancomycin for Skin and Soft Tissue Infections by Methicilin-Resistant Staphylococcus Aureus- A Cost Comparison Analysis Under the Private Payer Perspective in Brazil

    Nov 1, 2011, 00:00

  • PMS10 Cost-Effectiveness of Duloxetine Compared to Pregabaline in Patients with Fibromyalgia from the Public Health Care System perspective in México

    Nov 1, 2011, 00:00

  • PIN16 Rates and Predictors of Gonorrhea Re-Screening Among Privately Insured Patients with Gonorrhea in 2007-2009

    Nov 1, 2011, 00:00

  • PCV26 Real World Add-On and Switch Patterns for Platelet Aggregation Inhibitors

    Nov 1, 2011, 00:00

  • PUK11 Preliminary Cost-Minimization Analysis of Continuous Versus Intermittent Renal Replacement Therapy in Intensive Care Patients Experiencing Acute Renal Failure

    Nov 1, 2011, 00:00

  • PRM5 Novel Patient Reported Outcomes and Data Tool for Chronic Disease Management (PROCDIM)- Case in Point Prostate Cancer

    Nov 1, 2011, 00:00

  • PMH14 Speed of Detection of Adverse Events in Spontaneous Adverse Event Databases Compared with Epidemiological Studies- Two related Cases

    Nov 1, 2011, 00:00

  • PIH9 Follow Up Balance and Gait Examination During Pregnancy

    Nov 1, 2011, 00:00

  • PIH4 Analisis De Costo-Efectividad Del Uso De Levonorgestrel-Uis Frente A Otros Tratamientos En Menorragia Idiopatica

    Nov 1, 2011, 00:00

  • PSU14 Complications and Costs Associated with Tubal Ligations

    Nov 1, 2011, 00:00

  • PGI26 Evaluating the Impact of Gastrointestinal Episodes on the Health-related Quality of Life of Solid Organ Transplant Recipients- Validation of the SIGIT-QoL® Questionnaire – the Mypaciente 1 2 Studies

    Nov 1, 2011, 00:00

  • PIH6 Treatment Patterns and Associated Clinical and Economic Outcomes of Women Treated with Hormone Therapy

    Nov 1, 2011, 00:00

  • PGI17 Cost of Outpatient Endoscopic Capsule (EC) Procedure in Brazil- A Study from a Payer'S Perspective

    Nov 1, 2011, 00:00

  • PCN77 Cost-Effectiveness of Granulocyte Colony Stimulating Factor (G-CSF) in Primary (PP) and Secondary Prophylaxis (SP) of Febrile Neutropenia (FN) in Patients with Stages 2 and 3 Breast Cancer (BC) Undergoing Cytotoxic Chemotherapy in Fra ...

    Nov 1, 2011, 00:00

  • PIN53 Cost-Effectiveness Analysis of Pegylated Interferon Alpha-2A Versus Pegylated Interferon Alpha-2B in the Treatment of Chronic Hepatitis C Patients in Poland

    Nov 1, 2011, 00:00

  • PMD24 Cost-Effetiveness of 3M ™ Coban 2 ™ Compression System in the Treatment of Lymphoedema

    Nov 1, 2011, 00:00

  • PIN109 Modelling the Policy of Managing Seasonal Influenza in the UK

    Nov 1, 2011, 00:00

  • PCN47 Clinical and Economic Burden of Breast Cancer in Japan- A Diagnosis Procedure Combination–Based Claims Database Survey

    Nov 1, 2011, 00:00

  • PCN194 The Use of Large GPs Longitudinal Database in the Reasearch of Causal Associations Among Pathologies- The Case of Diabetes and Cancer Incidence

    Nov 1, 2011, 00:00

  • PRS33 A Cost-Effectiveness Analysis of Varenicline Versus Buproprion and Nicotine Replacement Therapy in Greece

    Nov 1, 2011, 00:00

  • PHP164 A Typology of Outcomes for Health Research

    Nov 1, 2011, 00:00

  • PCN24 Budget Impact Model for Rare Cancer Treatment- Case in Point Cutaneous T-Cell Lymphoma

    Nov 1, 2011, 00:00

  • PMS65 Quality of Life for Thai Hip Fracture Patients- Assessments with Medical outcomes Study, a 36-Item Short form Survey (MOS SF-36) and One-Year Health Care Resource Utilization in a Public Hospital

    Nov 1, 2011, 00:00

  • PMD10 Impact Analyses of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention in Patients with Multivessel Disease in France and Belgium

    Nov 1, 2011, 00:00

  • PHP70 Value Based Pricing (VBP)- Is This the Way Forward for the UK NHS?

    Nov 1, 2011, 00:00

  • PCN171 Underlying Causes for Sub-Optimal Utilisation of Cancer Drugs Funds in England

    Nov 1, 2011, 00:00

  • DA2 A Choice that Matters- Comparing Methods of Data Synthesis in Cost-Effectiveness Modelling

    Nov 1, 2011, 00:00

  • PND5 Efficacy and Safety of Immuno-regulatory Drugs, Interferons Beta and Glatiramer in Relapsing – Remitting Multiple Sclerosis

    Nov 1, 2011, 00:00

  • PSY43 The Translation and Linguistic Validation of the Treatment Related Impact Measure – Weight (Trim-Weight)

    Nov 1, 2011, 00:00

  • PCN200 Using A Weibull Parametric Model for Failure-Time Data to Assess Progression-Free Survival as A Surrogate Endpoint for Overall Survival in A Trial of Patients with Metastatic Renal Cell Carcinoma

    Nov 1, 2011, 00:00

  • PCV27 Frequency of Adverse Drugs Events (ADES) as Possible Causes of Request of Drugs Not Included in Essential Medicines List in Colombia

    Nov 1, 2011, 00:00

  • PHP119 Is There No Optimal Approach for Orphan Drugs to Patient Access? Rare Disease is Not Rare and Needs to Develop the New Pricing and Reimbursement Solution

    Nov 1, 2011, 00:00

  • PIH19 Public Health Costs Associated with Outbreaks of Meningoccocal Disease- A Systematic Review

    Nov 1, 2011, 00:00

  • PCV6 Comparison of Bleeding Rates between Statin and Statin-Free Patients on Warfarin- A Claims Database Approach

    Nov 1, 2011, 00:00

  • PIH29 the Cost Effectiveness of Clinically Proven Treatment Strategies for Attention-Deficit/Hyperactivity Disorder (ADHD) in Adult Patients

    Nov 1, 2011, 00:00

  • PMH70 Economic Impact of Focal Epilepsy in Spain- Results of the Espera Study

    Nov 1, 2011, 00:00

  • PMH79 The Impact of Comparative Effectiveness Research on Health and Health Care Spending

    Nov 1, 2011, 00:00

  • PMS40 Economic Evaluation of Etanercept in Rheumatoid Arthritis from the Public Payer perspective in Brazil

    Nov 1, 2011, 00:00

  • PCN153 Cost of Hospital Care in Population of Patients with Neoplasms in Poland

    Nov 1, 2011, 00:00

  • PCV1 Costs, Length of Stay and ALL-Cause Mortality in Ruptured Versus Unruptured Cerebral Aneurysm Among Inpatients in the United States

    Nov 1, 2011, 00:00

  • PHP110 Utilization of Physiotherapy Services in Hungary

    Nov 1, 2011, 00:00

  • PSU10 Economic Evaluation of Magnetic Resonance Guided Focused Ultrasound in Patients with Uterine Fibroids in Germany

    Nov 1, 2011, 00:00

  • PIN112 Use of Dynamic Models to Measure Health Outcomes of Pneumococcal Vaccination in Spanish Adult Population

    Nov 1, 2011, 00:00

  • PSU25 Effectiveness of Minimally Invasive Surgery for Total Hip Arthroplasty

    Nov 1, 2011, 00:00

  • PIN88 Late Immunization Doses Received by Children Younger than Two Years

    Nov 1, 2011, 00:00

  • PMS4 Economic Evaluation of Post-Operation orthopedic Surgery of antacid, antihemetic and analgesic Medication after Ketoprophene, Ketorolac, Parecoxib and Tenoxicam in Brazilian Patients

    Nov 1, 2011, 00:00

  • PSS1 Evaluacion Economica De Fototerapia De Banda Angosta O Fotoquimioterapia Para El Tratamiento De Psoriasis Desde La Perspectiva Del Instituto Mexicano Del Seguro SOCIAL

    Nov 1, 2011, 00:00

  • PDB59 Nocturnal Hypoglycemic Events- Impacts on Patients Functioing, Well-Being and Diabetes Management

    Nov 1, 2011, 00:00

  • PIH60 Changes in Blood Coagulation Properties Measured by Thrombelastometry During Spiroergometry in Sportsmen and in Sportswomen

    Nov 1, 2011, 00:00

  • PHP98 Exploring Regional Variation in Tariffs/Public Prices Across Autonomous Communities in Spain- The Case of Diagnosis Related Groups and ICD-9 Diagnostic Codes

    Nov 1, 2011, 00:00

  • PRS1 COST-Effectiveness Of Varenicline Versus Existing Smoking Cessation Strategies in Brazil from the Public Perspective, Using the Benesco Model

    Nov 1, 2011, 00:00

  • PRM11 Learning Effect in Economic Evaluations of Health Care Interventions

    Nov 1, 2011, 00:00

  • PMS23 Analysis of Indirect Costs for Care of Rheumatoid Arthritis Patients Using Large Cohort Database, Iorra, in Japan

    Nov 1, 2011, 00:00

  • PGI3 Current Treatments for Chronic Hepatitis B- A Systematic Review

    Nov 1, 2011, 00:00

  • PCV138 Using a Population- Based, Budget- Constrained, Cost-Effectiveness Model to Assess the Health and Economic Impacts of Using Statins for Primary Prevention Based on the Jupiter Trial intended Use Population

    Nov 1, 2011, 00:00

  • PCN102 Economic Evaluation of Three Formulations of Leuprolide Acetate With Atrigel® in Androgen Deprivation Therapy for Advanced Prostate Cancer in Nine European Countries

    Nov 1, 2011, 00:00

  • PND6 Outcomes of Antiepileptic Drugs Uses at Doses Above the Recommended Range Among Children with Structural-Metabolic Epilepsy in Malaysia

    Nov 1, 2011, 00:00

  • PMD46 Development of A Standard Reimbursement Dossier for the Evaluation of Effectiveness and Cost-Effectiveness of A New Medical Device (Nebulizer Mini-plus)

    Nov 1, 2011, 00:00

  • PND40 A Study to Estimate Utility Values for Different Levels of Severity of Migraine Pain

    Nov 1, 2011, 00:00

  • PCV23 Clopidodgrel and Statin Prescribing Patterns in ACS Patients – an Observational Study Using Linked Secondary and Primary Care Data in a UK Population 2003-2009

    Nov 1, 2011, 00:00

  • PCN23 Survival Analyses Adjusted for Crossover in Relapsed Multiple Myeloma- Results of the Apex Trial

    Nov 1, 2011, 00:00

  • PCV105 Using Theory of Reasoned Action Variables to Predict and Improve Statin Adherence

    Nov 1, 2011, 00:00

  • CV2 Cost-Effectiveness of Prasugrel Versus Clopidogrel in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention in the Private Sector in México

    Nov 1, 2011, 00:00

  • PMS50 Cost-Effectiveness of Biologic Agents Compared with Methotrexate in the Treatment of Rheumatoid Arthritis in Colombia

    Nov 1, 2011, 00:00

  • VA1 Evaluacion Rápida Del Impacto De La Introduccion De La Vacuna Contra El Rotavirus En Colombia

    Nov 1, 2011, 00:00

  • PRS61 Age has No Significant Impact on Health-Related Quality of Life in Patients Hospitalized for COPD Exacerbations

    Nov 1, 2011, 00:00

  • PCN6 Evaluacion Economica Del Dasatinib En El Tratamiento De La Leucemia Mieloide Cronica En Pacientes Resistentes Al Imatinib En Chile

    Nov 1, 2011, 00:00

  • PCN2 Cost-Effectiveness and Budget Impact Analysis of an Immediate Care Center at the National Cancer Institute, Mexico

    Nov 1, 2011, 00:00

  • PSY18 Resource Consumption Evaluation for Ketoprophene, Ketorolac, Parecoxib and Tenoxicam at Orthopedic Surgery Post-Operation in Brazilian Patients from Private Payers Perspective

    Nov 1, 2011, 00:00

  • PSY21 Predictors of Duloxetine Adherence and Persistence in Patients with Fibromyalgia

    Nov 1, 2011, 00:00

  • PCV45 Health Economic Evaluation of Ticagrelor in Patients with Acute Coronary Patients (ACS) Based on the Plato Study from A Spanish Health Care Perspective

    Nov 1, 2011, 00:00

  • PMH31 Cost-Effectiveness of Long-Acting Olanzapine Versus Long-Acting Risperidone in Patients with Schizophrenia in Spain

    Nov 1, 2011, 00:00

  • NI4 The Association between Financial Impact and the likelihood of recommendation of Medicines for Use in England and Wales

    Nov 1, 2011, 00:00

  • PSY42 Chronic Pain- Patient Treatment Preferences - a Discrete Choice Experiment

    Nov 1, 2011, 00:00

  • PMH7 Aasenapine Versus Other Antipsychotics in Bipolar I Disorder- Indirect Comparisons at Twelve Weeks

    Nov 1, 2011, 00:00

  • PHP159 Structures for the Role of Health Technology Assessment in Translational Research

    Nov 1, 2011, 00:00

  • PMH21 Economic Cost of Alcohol and Drug Abuse in Washington State, USA

    Nov 1, 2011, 00:00

  • PCV64 the Potential Clinical and Economic Outcomes of Pharmacogenetic-Oriented Warfarin Therapy in Russia

    Nov 1, 2011, 00:00

  • PRS51 The Development of the Early Morning Symptoms of COPD Instrument (EMSCI)

    Nov 1, 2011, 00:00

  • IN3 Dengue MÁs Que Un Problema De Salud PÚblica- EstimaciÓn De Los Costos Directos De La Epidemia Del AÑo 2010 En Colombia

    Nov 1, 2011, 00:00

  • PHP15 Price Negotiations in Korean Pharmaceutical Benefit System- How Compatible with CEA?

    Nov 1, 2011, 00:00

  • PCV76 A Cost-Effectiveness Analysis of Clopidogrel in Patients with Non Stable Acute Coronary Syndrome in Greece

    Nov 1, 2011, 00:00

  • PRM14 Mondriaan- A Dutch 'Population' Laboratory

    Nov 1, 2011, 00:00

  • PC1 The Use and Performance of Productivity Scales to Evaluate Presenteeism in Mood Disorders

    Nov 1, 2011, 00:00

  • PMD60 Development and Content Validity of the COPD Device Preference Questionnaire

    Nov 1, 2011, 00:00

  • PCV84 Resource Utilization and Costs for Candesartan in Heart Failure- Assessment of Reduction in Mortality and Morbidity (CHARM) Programme for the Austrian Setting

    Nov 1, 2011, 00:00

  • PSS24 Cost-Effectiveness of Ustekinumab vs Etanercept for Severe Psoriasis

    Nov 1, 2011, 00:00

  • PSS42 Evaluation of the Impact of Writing Exercises and Educational Interventions on Quality of Life in Patients With Psoriasis

    Nov 1, 2011, 00:00

  • PHP58 Towards Cost-Effectiveness Analysis of the Health and Wellbeing Benefits of Urban Green Spa A Mapping Review

    Nov 1, 2011, 00:00

  • UT1 Combining DCE and TTO Into A Single Value Function

    Nov 1, 2011, 00:00

  • PSS32 Impact of Dry Eye on Everyday Life (Ideel) - Symptom Bother- Estimating Cut-off Scores for Dry Eye Severity Groups

    Nov 1, 2011, 00:00

  • PDB9 Weight Loss, Independent of Drug Class, Predicts HbA1c Goal Attainment in Patients 65 Years and Older in a Real-World Setting

    Nov 1, 2011, 00:00

  • PND48 Development of A Burden Questionnaire- Family Burden of Ichthyosis in Infants

    Nov 1, 2011, 00:00

  • PHP65 Pharmaceutical Expenditure in Portugal – Policies and Impact

    Nov 1, 2011, 00:00

  • PIH32 What are the Factors Influencing Parental Apprehension About Consenting Children to Participate in Pediatric Observational Studies? A Survey Conducted in France with in Fine Pharma, a Pharmacist Network

    Nov 1, 2011, 00:00

  • PHP7 Impact of Global Health Care Reforms on Pricing, Access and Health Economics and outcomes Strategy

    Nov 1, 2011, 00:00

  • AD1 Compliance Measurement Using Administrative Data From German Sickness Funds

    Nov 1, 2011, 00:00

  • PCN191 Economic Evaluation of XELOX vs FOLFOX4 as Adjuvant Treatment for Patients with Stage III Colon Cancer in south Korea

    Nov 1, 2011, 00:00

  • PRS28 Adherence to Current Guidelines for Chronic Obstructive Pulmonary Disease (COPD) in Subjects Treated with Combination of Long-Acting β2-Agonist (LABA), LONG-Acting Muscarinic Antagonist (LAMA) or Inhaled Corticosteroids (ICS)

    Nov 1, 2011, 00:00

  • PHP76 The Lack of BIA Methodology in the Czech Republic Leads to Inappropriate Public Health Insurance Budgeting

    Nov 1, 2011, 00:00

  • PIH2 Addressing Childhood Obesity In Mexico- Savings On Health Care Expenditures From Regulating Food And Beverage Sales In Basic Education Schools

    Nov 1, 2011, 00:00

  • PHP160 Introducing the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP)- A Bridge Between Medicines Regulation and Health Outcomes Research

    Nov 1, 2011, 00:00

  • PIN52 Cost-Effectiveness of Rifampicin-Based Continuation Phase of Tuberculosis Treatment in Uganda

    Nov 1, 2011, 00:00

  • PCV141 Current Management Pathway of Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention in Greece. Results from Aptorii Study

    Nov 1, 2011, 00:00

  • PRM62 The Impact of Centre Selection on the Generalisability of Economic Evaluation Results from Multi-Centre Randomised Controlled Trials

    Nov 1, 2011, 00:00

  • PGI27 Sleep Disturbance and Quality of Life Among Hepatitis C Infected Individuals

    Nov 1, 2011, 00:00

  • PMH66 12-Year Trend Analysis on the Characteristics, Primary Payer, and Prescribed Medications of Physician-Office Visits for Patients with Dementia in the United States

    Nov 1, 2011, 00:00

  • PSY52 Impact of Two Different Treatment Approaches on Epidemiology of inhibitor Hemophilia in Russia

    Nov 1, 2011, 00:00

  • PHP38 Health Technology Assessment Applied to Medical Devices in Latin America- What Must Be Assessed

    Nov 1, 2011, 00:00

  • PCN159 Diagnostics and Treatment of Patients with Non-Small-Cell Lung Cancer in Daily Practice

    Nov 1, 2011, 00:00

  • PSS16 Cost of Blindness in Austria

    Nov 1, 2011, 00:00

  • PRS74 Measurement Of A Possible Patch Testing Outcome Indicator

    Nov 1, 2011, 00:00

  • PIN23 To Assess or Not To Assess- That is the Question! Budget, Ethical and Decisional Impact assessment in HIV- Lombardy Region's Molo Project

    Nov 1, 2011, 00:00

  • PIN8 Evaluacion Economica De La Extension De Profilaxis Contra CMV De 100 A 200 Dias En Receptores De Trasplante Renal Con Alto Riesgo (D+ / R−)

    Nov 1, 2011, 00:00

  • PIN56 Cost-Effectiveness Model to Evaluate 200-Day vs 100-Day Treatment with Valganciclovir Prophylaxis to Reduce Cytomegalovirus Disease in High-Risk (D+/R-) Kidney Transplant Recipient in Spain

    Nov 1, 2011, 00:00

  • PDB44 An Economic Evaluation of the Use of Pioglitazone in Italy Using Proactive

    Nov 1, 2011, 00:00

  • PHP8 ATC Classification and Its Role in Pricing Policies

    Nov 1, 2011, 00:00

  • PCN88 Economic Model of Granulocyte-Colony Stimulating Factor (G-CSF) in Primary (PP) and Secondary Prophylaxis (SP) of Febrile Neutropenia (FN) in Non-Hodgkin'S Lymphoma (NHL) Patients Undergoing Chemotherapy in France

    Nov 1, 2011, 00:00

  • PHP67 Tendering for Outpatient Prescription Pharmaceuticals- What Can Be Learned from Current Practices in Europe?

    Nov 1, 2011, 00:00

  • PHP168 Endogenous Cost-Effectiveness Analysis in Health Care Technology Adoption

    Nov 1, 2011, 00:00

  • PDB47 Understanding the Implications of Incorporating the UKPDS Glycaemic Legacy Effect Into Evaluating the Cost-Effectiveness of Type 2 Diabetes Therapies

    Nov 1, 2011, 00:00

  • PIN90 Discrete Choice Experiments (DCES) in HIV/AIDS Treatment- Expert Judgement in Comparison to Patient Preferences

    Nov 1, 2011, 00:00

  • PRS75 Health Technology Appraisal of New Drugs- Are we Getting it Right?

    Nov 1, 2011, 00:00

  • PGI6 The Development and External Validation of a Model to Predict One Year All-Cause Mortality Following Liver Function Tests in Primary Care Patients

    Nov 1, 2011, 00:00

  • PND33 Cost Minimization Analysis of Fingolimod Compared to Natalizumab in Patients with Relapse Remitting Multiple Sclerosis in the Netherlands

    Nov 1, 2011, 00:00

  • PDB67 Treatment Patterns and Health Outcomes Among Type 2 Diabetes with Comorbid Obesity in France, Germany, And UK

    Nov 1, 2011, 00:00

  • PMD52 Workload in German Hospitals Caused by Routine Follow-up Services for Cardiac Implantable Electrical Devices (CIED)

    Nov 1, 2011, 00:00

  • PCV62 Influence of Smoking on the Use of Health-Care resources and Costs in Patients with Cardiovascular Disease

    Nov 1, 2011, 00:00

  • PMS29 Abatacept or Infliximab for Patients with Rheumatoid Arthritis and Inadequate Response to Methotrexate- A Trial-Based and Real-Life Cost-Consequence Analysis

    Nov 1, 2011, 00:00

  • PCV75 Cost-Effectiveness of Optimizing Use of Statins in Australia- Using Outpatient Data from the REACH Registry

    Nov 1, 2011, 00:00

  • PSY3 The Potential Impact of Obesity Degree on Diabetes, Heart Attack, Hypertension, Chronic Anxiety and Depression in Adult Spanish Population

    Nov 1, 2011, 00:00

  • PRM53 Comparing Multiple Propensity Score Adjustment and Traditional Regression Analysis to Assess the Exposure-Outcome Association Using Retrospective Claims Data

    Nov 1, 2011, 00:00

  • PCV6 Cost-Effectiveness and Budget Impact Analysis of Rivaroxaban in the Prevention of Thromboembolic Events in Patients Performing Hip and Knee Arthroplasty in Comparison With Enoxaparin Under the Brazilian Private Health Care System Persp ...

    Nov 1, 2011, 00:00

  • PDB78 Reasons of UK General Practitioners for Prescribing 15- or 30-Mg of Pioglitazone in Combination with Other Oral Antihyperglycaemic Agents

    Nov 1, 2011, 00:00

  • PCV139 Epidemiology and Economic Burden of Atrial Fibrilation to the Public Health Care System in Brazil

    Nov 1, 2011, 00:00

  • PIN3 Comparing the Efficacy and Tolerability of Anti-Retroviral Therapy in Treatment-Naïve HIV-1 Infected Adults- A Systematic review of Randomized Clinical Trials and Bayesian Mixed Treatment Comparisons Including Atazanavir/R, Darunavir/R ...

    Nov 1, 2011, 00:00

  • PHP2 Relation Between Consumer Behaviour and Drug Safety Monitoring in France

    Nov 1, 2011, 00:00

  • PRM25 Switch of Prescription Drugs to the Over-the-Counter Status (Rx-to-OTC)- The Development of a Flexible and Generic European Budget Impact Model

    Nov 1, 2011, 00:00

  • PRM4 Measuring Comorbidity in Administrative Data

    Nov 1, 2011, 00:00

  • PRM60 Assessing Relative Clinical Value Across Tumor Types in Metastatic Disease

    Nov 1, 2011, 00:00

  • PRS42 Pharmacoeconomic Analysis of Methylprednisolone Aceponate for Treatment of Atopic Dermatitis and Eczema

    Nov 1, 2011, 00:00

  • PIN92 Patient Reported Outcomes Among Chronic Hepatitis C Patients Re-Treated with Peginterferon Alfa-2A/Ribavirin After Non-response to Peginterferon Alfa-2B/Ribavirin in Spain

    Nov 1, 2011, 00:00

  • PDB6 Description of Comorbidities and Body Mass Index in US Adults with and Without Diabetes from the Medical Expenditure Panel Survey, 2008

    Nov 1, 2011, 00:00

  • PCV56 the Economic Burden of Atherothrombosis in Gree Results from the Thesis Study

    Nov 1, 2011, 00:00

  • PGI33 Predictors of Direct Medical Costs of Crohn'S Disease and Ulcerative Colitis

    Nov 1, 2011, 00:00

  • HT2 Value Based Pricing- One Threshold too Far for the United Kingdom

    Nov 1, 2011, 00:00

  • PSY55 Cost of Autologous and Allogeneic Stem Cell Transplantations for Haematological Disease- A Dutch Multicentre Daily Practice Study

    Nov 1, 2011, 00:00

  • PCN123 A Literature Review on Utility Values Associated With HPV-Related Diseases

    Nov 1, 2011, 00:00

  • PSY26 Cost Benefit Analysis of a Worksite Weight Management Program

    Nov 1, 2011, 00:00

  • PMS26 Cost of Dupuytren Contracture in the Czech Republic

    Nov 1, 2011, 00:00

  • PRS5 Cost-Effectiveness of Varenicline vs Existing Smoking Cessation Strategies in Dominican republic Using the Benesco Model

    Nov 1, 2011, 00:00

  • PRM46 Linguistic Validation and ePRO – Value of Collaboration

    Nov 1, 2011, 00:00

  • PRS8 Predicted Survival for North American Patients with Cystic Fibrosis Adjusted for Cohort Specific Covariates

    Nov 1, 2011, 00:00

  • PRM44 The First Research- Assessment of the WTP Threshold for QALY by Contingent Valuation Method in Russia

    Nov 1, 2011, 00:00

  • PCN30 Comparative Analysis of Cost and Resource Use Among Patients With Brain Metastasis by Initial Primary Cancer

    Nov 1, 2011, 00:00

  • PMD54 Resource Utilisation Related to Catheter-associated Urinary Tract infections in Swedish Spinal injury Patients

    Nov 1, 2011, 00:00

  • PHP51 Pill Burden in South African Patients With Multiple Risk Factors for Metabolic Syndrome

    Nov 1, 2011, 00:00

  • PHP146 Current Status and Trends in Performance-Based Schemes Between Health Care Payers and Manufacturers

    Nov 1, 2011, 00:00

  • PIN4 Economic Impact Of Community Acquired Pneumonia Hospitalizations In Adults In Six Countries In Latin America

    Nov 1, 2011, 00:00

  • PSU11 Medico-Economic Analysis of the Impact of Malnutrition on the Post-Operative Course of Colorectal Cancer Patients

    Nov 1, 2011, 00:00

  • PIH46 Satisfaction with Prescription and Over-the-Counter Medications- Results from a Novel Patient Registry

    Nov 1, 2011, 00:00

  • PRS13 Specific Immunotherapy and the Economic Implications from the Perspective of German Statutory Health Insurance - a Budget-Impact Modeling Approach

    Nov 1, 2011, 00:00

  • PIN75 Cost-Effectiveness of Polysaccharide Pneumococcal Vaccination in People Aged 65 and Above in Poland

    Nov 1, 2011, 00:00

  • PHP95 Payer Perspectives on Evidence for Formulary Decision Making in the United States

    Nov 1, 2011, 00:00

  • PMH32 Cost-Effectiveness of Agomelatine in the Treatment of Major Depressive Episodes in Thailand

    Nov 1, 2011, 00:00

  • PCN28 Capecitabine for the Treatment of Breast Cancer in Private Health System in Brazil- Cost analysis Based on Real World Data

    Nov 1, 2011, 00:00

  • PCN15 Dance as Physiotherapy in the Rehabilitation of Women Suffering from Tumour

    Nov 1, 2011, 00:00

  • EX4 Efectividad De Los indicadores De Calidad De La Prescripción Regionales En El Sns Español

    Nov 1, 2011, 00:00

  • PHP3 Patient Preferences Considering the Choice of Health Care Providers in Hungary – Results From Discrete Choice Experiment

    Nov 1, 2011, 00:00

  • HS4 Impacto Economico En La Atencion Medica De Enfermedades Asociadas Al Tabaquismo En Una Poblacion Mexicana

    Nov 1, 2011, 00:00

  • PIH52 Medicine Prescribing Patterns in HIV/AIDS and Non-HIV/AIDS Children- A Comparitive Study in the Private Health Care Sector of South Africa

    Nov 1, 2011, 00:00

  • PCN157 The Impact of a Patient Support Program on Access to Oral Oncology Therapy in the United States

    Nov 1, 2011, 00:00

  • PCN141 Quality of Life in Small Cell Lung Cancer- Results of an Open-Label Phase III Clinical Trial

    Nov 1, 2011, 00:00

  • PIH14 Rates and Predictors of Chlamydia re-Screening among Privately insured Patients with Chlamydia in 2007- 2009

    Nov 1, 2011, 00:00

  • PDB76 Knowledge, Medication Adherence and Glycemic Control Among Patients with Type 2 Diabetes Mellitus

    Nov 1, 2011, 00:00

  • PDB66 Achievement of Glycemic Control and Relapse Among Patients Initiating Basal Insulin from a Geographically-Diverse Us Electronic Medical Record (EMR) Database

    Nov 1, 2011, 00:00

  • PHP19 Increased Market Share of Private, For-Profit Health Care Providers From the Hungarian Health Insurance Budget Between 2006-2009

    Nov 1, 2011, 00:00

  • PMH18 The Economic and Social Consequences of Seroquel XR® (Quetiapine Prolonged Release Tablets) Reimbursement in Bipolar Disorder Treatment for Patients Currently Treated with Seroquel (Quetiapine Immediate Release Tablets) in Poland- Ana ...

    Nov 1, 2011, 00:00

  • PDB9 Analisis De Costo–Efectividad Del Uso De Detemir En Diabetes Tipo 2 Frente Al Riesgo De Presentar Eventos Cardiovasculares Y Muerte

    Nov 1, 2011, 00:00

  • PRM43 Direct from the Patients – Research Into What Patients Would Like to Improve in Their Electronic Diary Experience

    Nov 1, 2011, 00:00

  • PCN143 Electronic Patient-Reported Outcome Monitoring in Testicular Cancer Patients

    Nov 1, 2011, 00:00

  • PMS57 Preliminary Psychometric Validation of the Sleep Disturbance and Sleep Adequacy Subscales of the 1-Week Recall Medical outcomes Study Sleep Scale in Patients with Rheumatoid Arthritis

    Nov 1, 2011, 00:00

  • PHP71 Effect of SIADH on Patient outcomes and Health Care Resource Utilization in Hospitalized Patients

    Nov 1, 2011, 00:00

  • PDB23 Budget Impact Analysis of the Reimbursement of Long-Acting Insulin Analogues in Poland

    Nov 1, 2011, 00:00

  • PCN3 Estimacion De La Carga De Los Tumores Neuroendocrinos En Colombia

    Nov 1, 2011, 00:00

  • PND3 Risk-Benefit Analysis of Therapy in Multiple Sclerosis

    Nov 1, 2011, 00:00

  • PMS38 A Structured Literature Review of Rheumatoid Arthritis Economic Models for Biologics

    Nov 1, 2011, 00:00

  • PCV25 Characterising Patients with A First-Time Admission for atrial Fibrillation in the United Kingdom

    Nov 1, 2011, 00:00

  • PCN92 The Cost-Effectiveness of Nanoparticle Albumin-Bound Paclitaxel Compared to Solvent-Based Paclitaxel in Women with Metastatic Breast Cancer

    Nov 1, 2011, 00:00

  • PCN22 Safety Profile of Bevacizumab in Metastatic Colorectal Cancer

    Nov 1, 2011, 00:00

  • PMS60 Experiences of Patients with Rheumatoid Arthritis in the US and UK- A Cross-Cultural Comparison

    Nov 1, 2011, 00:00

  • PCN177 Assessment of Reimbursement Processes and Outcomes for Cancer Drugs in Croatia – Comparison to NICE and NCCN Guidelines

    Nov 1, 2011, 00:00

  • PCV132 Do Atrial Fibrillation (AF) Patients Get Oral Anticoagulation (OAC) as Guidelines Recom-Mend? An Analysis of German Health Insurance Claims Data

    Nov 1, 2011, 00:00

  • PIN78 Cost Utility of Infant Vaccination Against Respiratory Syncytial Virus Infection in the Netherlands

    Nov 1, 2011, 00:00

  • PHP81 Funding Sources Analysis Results (Regional and Federal Levels) of Pharmaceutical Markets per Regions of Russian Federation

    Nov 1, 2011, 00:00

  • PND23 Cost of the Informal Care of Multiple Sclerosis in Spain

    Nov 1, 2011, 00:00

  • DA4 Finding Treatment Effects within Subgroups when Using the propensity Score to Control for Selection Bias- A Monte Carlo Simulation Study

    Nov 1, 2011, 00:00

  • PCN115 Cost of Skeletal-Related Events (SREs) in Patients with Bone Metastases to solid Tumours Based on the Health Resource Utilisation (HRU) Collected in a Prospective European Multinational Observational Study

    Nov 1, 2011, 00:00

  • MA4 Modelling EQ-5D Health State Values- Developing A Limited Dependent Variable, Mixture Modeling Approach

    Nov 1, 2011, 00:00

  • PND62 What Are The Key Drivers for Changing HTA Decisions? Example of Alzheimer'S Disease Treatment in Germany, France and UK

    Nov 1, 2011, 00:00

  • PCV74 Is Treatment of Depression Cost Effective in the Management of People with CHD and Diabetes- A Systematic Review of the Economic Evidence

    Nov 1, 2011, 00:00

  • PMD78 Benefit-Risk Analysis in Absence of Clinical Eviden Deciding for Treatment of Skull Deformity in Babies Aged 5 Months

    Nov 1, 2011, 00:00

  • PRS65 The Effect of Omalizumab on Unscheduled Healthcare Resource Utilisation and Health-Related Quality of Life in UK Clinical Practi The Apex Study

    Nov 1, 2011, 00:00

  • PCN176 Cancer Drug Prices in the United States and the United Kingdom- Implications for Pricing Strategy and Drug Access

    Nov 1, 2011, 00:00

  • PHP13 A Survey of Pricing Trends Around the World

    Nov 1, 2011, 00:00

  • PGI16 Comparison of Treatment and Indirect Costs Between Hepatitis, Cirrhosis, Liver Transplantation and Hepatic Carcinoma- Results of the Come Study

    Nov 1, 2011, 00:00

  • PMH33 The Cost-Effectiveness of Paliperidone ER in Spain

    Nov 1, 2011, 00:00

  • PCV143 Implementation of Evidence-Based National Guidance on Venous Thrombo-Embolism Prophylaxis for Hospital Inpatients in England

    Nov 1, 2011, 00:00

  • PSY23 Pregabalin is Associated with Lower Health Care Costs and Less Absenteeism than Gabapentin when Added to the Treatment of Neuropathic Pain

    Nov 1, 2011, 00:00

  • PGI22 The Extra Health Care Costs Associated Withantimicrobial Prophylaxis in Colorectal Surgical Patients- An Exploration of Profiling Data from a University Hospital in Japan

    Nov 1, 2011, 00:00

  • PRS56 Assessing Patient Report of Function- Content Validity of the Functional Performance Inventory-Short form (FPI-SF) in Patients with Chronic Obstructive Pulmonary Disease

    Nov 1, 2011, 00:00

  • PSS3 Un Estudio De Costo-Efectividad Para Evaluar El Tratamiento Con N-Acetil Cisteína En Pacientes Con Esclerosis Sistémica

    Nov 1, 2011, 00:00

  • PCV41 The Budgetary Impact of Implementing A Telehealth Home Monitoring System for Chronic Heart Failure Patients in a Typical UK Primary Care Trust

    Nov 1, 2011, 00:00

  • PDB11 Economic Evaluation of Teripatide in the Management of Women with Postmenopausal Osteoporosis and High Risk of Fragility Fractures in Mexico

    Nov 1, 2011, 00:00

  • HG4 The Value of Heterogeneity for Cost-Effectiveness Subgroup Analysis- Theoretical Framework and Application

    Nov 1, 2011, 00:00

  • PCV119 Relationship Between Quality of Life and Level of Cardiovascular Risk and Comorbidities in Spanish Hipertensive Patients-Alhambra Study

    Nov 1, 2011, 00:00

  • PSS5 Visual Field Evolution in Glaucoma Patients Presenting With Different Disease Stages- Results From an Observational Study

    Nov 1, 2011, 00:00

  • PCN70 Cost-Effectiveness of Cetuximab and Bevacizumab in the First-Line Treatment of Metastatic Colorectal Cancer (mCRC) for Patients with Kras Wild-Type Tumours in the United Kingdom

    Nov 1, 2011, 00:00

  • PHP20 Market Access Barriers for Biosimilars in Spain and Germany- Epoetin Alfa Example

    Nov 1, 2011, 00:00

  • IN2 Chronic Hepatitis C Treatment For Genotype 2 Or 3- COST-Effectiveness Analysis of Peg as First Line Treatment With the Brazilian Protocol

    Nov 1, 2011, 00:00

  • PMS9 What is the Value of the New Kid on the Block?- tocilizumab versus Abatacept for Rheumatoid Arthritis in Colombia

    Nov 1, 2011, 00:00

  • PND13 Management of Focal Epilepsy Treated by Polytherapy in Fran The Cost of Pharmaco-Resistance

    Nov 1, 2011, 00:00

  • PGI8 Cost Analysis and Incidence of Adverse Gastrointestinal Events Following Bisphosphonate Treatment Among Women with Osteoporosis in Taiwan

    Nov 1, 2011, 00:00

  • PMS39 Economic Evaluation of Tocilizumab for the Treatment of Systemic Juvenile Idiopathic Arthritis in Mexico

    Nov 1, 2011, 00:00

  • PHP27 The Economic Benefits of Implementing A Unit Dose Drug Dispensing System at the Hospital Level in the Mexican Institute of Social Security (IMSS)

    Nov 1, 2011, 00:00

  • PIN99 Modelling the Impact of Extended Vaccination Strategies on the Epidemiology of Pertussis

    Nov 1, 2011, 00:00

  • PIN11 Evaluacion Economica De Las Vacunas Conjugadas De Pneumococo Para Peru

    Nov 1, 2011, 00:00

  • PCN125 Elicitation of Health State Utilities in Neuroendocrine Tumours

    Nov 1, 2011, 00:00

  • PIN35 Costs of Managing Genital Warts in the UK

    Nov 1, 2011, 00:00

  • PCN173 Cancer Incidence Evaluation and Pathway Identification for Treatment Course Detection Using Billing Data for Austria

    Nov 1, 2011, 00:00

  • PMS64 Sensitivity of Pro'S to Detect Changes in Quality of Life in Patients Treated with a Biologic Agent

    Nov 1, 2011, 00:00

  • PND34 Cost-Utility Analysis of Lacosamide Adjunctive Therapy in the Treatment of Patients With Refractory in the Slovak Republic

    Nov 1, 2011, 00:00

  • PND57 Effect of Treatment Timing on Risk of Institutionalization Among Patients with Alzheimer'S Disease

    Nov 1, 2011, 00:00

  • PRM19 Modelling the Impact of Multiple Indication Drug Launch on Total Revenue

    Nov 1, 2011, 00:00

  • PND38 International Comparison of Huntington Disease (HD) Burden

    Nov 1, 2011, 00:00

  • PRS73 Systematic Review of the Guidelines on the Prevention of Allergic Manifestations in Children

    Nov 1, 2011, 00:00

  • PMS22 The Burden of Illness of Osteoporosis in Canada

    Nov 1, 2011, 00:00

  • PMS66 Conceptual Model of the Impact of Hip Fracture on Patients' Lives

    Nov 1, 2011, 00:00

  • PHP117 The Cost-Effectiveness Threshold- The Results of A Novel Literature Review Method

    Nov 1, 2011, 00:00

  • PSS44 Using Structural Equation Modeling to Investigate the Association of Treatment Satisfaction With Disease Severity and Health Related Quality of Life

    Nov 1, 2011, 00:00

  • PSY2 ESTIMACIÓn Del Impacto Financiero En La Salud De La POBLACIÓn Mexicana Derivado De La Obesidad Y El Sobrepeso, 2000-2017

    Nov 1, 2011, 00:00

  • PSS14 Burden of Disease in Patients With Severe Chronic Hand Eczema in Germany

    Nov 1, 2011, 00:00

  • PCN2 A Retrospective Longitudinal Study of Treatment Patterns and Outcomes Among Patients with Unresectable Stage IIIc/IV Melanoma in Canada (Melody)

    Nov 1, 2011, 00:00

  • PSY28 Cost-Effectiveness Analysis Comparing Epidural, Patient-Controlled Iv Morphine, and Continuous Wound Infiltration for Postoperative Pain Management After Abdominal Surgery

    Nov 1, 2011, 00:00

  • PIN40 Linezolid Versus Vancomycin for Skin and Soft Tissue Infections by Methicilin-Resistant Staphylococcus Aureus- A Cost Comparison Analysis Under the Public Hospital Perspective in Brazil

    Nov 1, 2011, 00:00

  • ISPOR 14th annual European congress financial disclosure information for research presetnations

    Nov 1, 2011, 00:00

  • PIN54 Cost-Effectiveness of 2+1 Dosing of 13-Valent Pneumococcal Conjugate Vaccine Compared with 2+1 Dosing of 10-Valent Conjugate Vaccine in Preventing Pneumococcal Disease in Canada

    Nov 1, 2011, 00:00

  • PRS35 Economic Evaluation of Indacaterol Versus Tiotropium or Formoterol for Patients with Moderate to Severe Copd in Greece

    Nov 1, 2011, 00:00

  • PCN67 Erlotinib as Second Line Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC)- Economic Modeling (EM) results

    Nov 1, 2011, 00:00

  • PGI1 Resource Utilization and Cost of Management of Complex Perianal Fistula in Crohn's Disease in Spain

    Nov 1, 2011, 00:00

  • PIN65 Health Economic Model on the Costs and Effects of Rota Virus Vaccination in Germany

    Nov 1, 2011, 00:00

  • PHP21 Adoption of New Medicines in the OECD- Regulation, Innovation and Scale

    Nov 1, 2011, 00:00

  • PIN6 Evaluacion COSTO-Efectividad Del Uso De Linezolid En El Tratamiento De Neumonias Nosocomiales En MÉXICO

    Nov 1, 2011, 00:00

  • PIH53 Alpha Blockers, 5-Alpha Reductase Inhibitors, PDE-5 Inhibitors and Antimuscarinic Medication Use in US Patients Diagnosed with Benign Prostatic Hyperplasia, and Lower Urinary Tract Symptoms with and Without Erectile Dysfunction

    Nov 1, 2011, 00:00

  • PMS79 Mixed Treatment Comparison of Biologic Agents in Patients with Rheumatoid Arthritis Who Have responded Inadequately to Methotrexate Therapy in the United Kingdom

    Nov 1, 2011, 00:00

  • PCV135 Low Lipoprotein Cholesterol Goal Attainment in Dyslipidemic Patients with Existing Statin therapy- A Chart Extraction-Based Approach

    Nov 1, 2011, 00:00

  • PSS20 Annual Cost of Biological Therapies for the Treatment of Moderate to Severe Plaque Psoriasis in Spain

    Nov 1, 2011, 00:00

  • PHP36 Perceptions of Policy Makers and Science Advice Body Staff on Science Advice in Health in Europe

    Nov 1, 2011, 00:00

  • PMD58 Provision and Financing of Medical Aids in the Management of Rare Diseases- The Case of Amyotrophic Lateral Sclerosis (ALS)

    Nov 1, 2011, 00:00

  • PUK2 Cost Per Successful Response Of Standard Treatment Plus Cinacalcet Versus Standard Treatment Alone In Patients With Secondary Hyperparathyroidism In MEXICO

    Nov 1, 2011, 00:00

  • PCV48 Clinical Outcomes and Costs Associated with Stroke in Patients with Non-Valvular Atrial Fibrillation

    Nov 1, 2011, 00:00

  • PSY58 Responsiveness of the Treatment Satisfaction with Medicines Questionnaire (Satmed-Q) in a Longitudinal Sample of Patients with Neuropathic Pain

    Nov 1, 2011, 00:00

  • PIN1 The Epidemiologic Burden Of Hepatitis C Virus Infection In Latin America

    Nov 1, 2011, 00:00

  • CN4 Heterogeneity In Predicting The Future Impact Of Technologies To Control Hepatocellular Carcinoma (HCC)- A Comparison Of Stakeholder Views From Europe And Asia

    Nov 1, 2011, 00:00

  • PRM4 A MIXED-Effects Piecewise Linear Model Of The Rate Of Lung Function Decline Before And After Inhaled Corticosteroids In An Observational Study Of Children With Cystic FIBROSIS

    Nov 1, 2011, 00:00

  • PCV133 Baseline Characteristics, Intervention Modalities and Utilization of Evidence Based Medications Among ACS Patients- Does Presence of Diabetes Affect the Presentation as Well as Management Scenario for ACS? – Results from Single Centr ...

    Nov 1, 2011, 00:00

  • PIN85 Costs of Influenza and Influenza Like Illness from the Employer's Perspective in Poland

    Nov 1, 2011, 00:00

  • PHP33 Impact of 2011 German Health Care Reform on Global Market Access Strategies

    Nov 1, 2011, 00:00

  • PSU1 Suprapubic Tube Placement Related Bowel Injury- Proposed Guidelines for Open Placement

    Nov 1, 2011, 00:00

  • PIH41 Are Different Spanish Versions of Pro Measures Necessary? The Case Study of the Pedsql™ 4.0 Generic Core Scales

    Nov 1, 2011, 00:00

  • PGI4 Health-Related Quality of Life Improvements in Patients with Active Crohn's Disease Following Treatment with Certolizumab Pegol in the Music Study (NCT00297648)

    Nov 1, 2011, 00:00

  • PMS18 Burden of Rheumatoid Arthritis in the Czech Republic – Direct and productivity Costs

    Nov 1, 2011, 00:00

  • PRM61 Sample Size Estimation for Prospective Observational Studies

    Nov 1, 2011, 00:00

  • PRS26 Direct Costs of Pneumonia in the United States- An Analysis of 2008 Medical Expenditure Panel Survey (MEPS) Data

    Nov 1, 2011, 00:00

  • PND10 Budget Impact Analysis of the Introduction of Fampridine to Improve Ambulation in Patients with Multiple Sclerosis (MS) in the UK

    Nov 1, 2011, 00:00

  • PHP32 Market Access Variation for Lifestyle Disease Drugs in Europe

    Nov 1, 2011, 00:00

  • PIH7 The Efficiency of in Vitro Fertilization in Hungary 2000-2010

    Nov 1, 2011, 00:00

  • PHP130 Using Economic Evidence and Stakeholder'S Participation in Decision Making on Benefit Package of Public Health insurance in Thailand

    Nov 1, 2011, 00:00

  • PND59 A Common Road Map for Rational Clinical and Policy Decisionmaking- Application of the MCDA-Based Evidem Framework to Growth Hormone Use in Patients with Prader-Willi Syndrome

    Nov 1, 2011, 00:00

  • PCN10 Analisis De Minimizacion De Costos Entre El Uso De Iopromide Mediante Un Sistema De Aplicacion En Cascada (SIAC) Frente Al Uso De Otros Medios De Contraste Convencionales En Radiologia Invasiva En Colombia

    Nov 1, 2011, 00:00

  • PCN8 Incidence, Predictive Factors, and Infection Complications of Prolonged Neutropenia in R-CHOP/CHOP Treated Diffuse Large B-Cell Lymphoma Patients

    Nov 1, 2011, 00:00

  • PHP36 Historical and Future Drivers for HTA in Reimbursement Systems in Mexico and Poland

    Nov 1, 2011, 00:00

  • PCN91 Pharmacoeconomic Analysis of mCRC Therapy With XELOX/FOLFOX4 Regimes With Bevacizumab or Cetuximab as the First Line Treatment in Russia

    Nov 1, 2011, 00:00

  • PCN90 Cost-Effectiveness Analysis of Erlotinib Versus Docetaxel, Pemetrexed for Second-Line Treatment of Advanced Non-Small-Cell Lung Cancer in Russia

    Nov 1, 2011, 00:00

  • PCV55 Clinical and Economical Burden of Oropharyngeal Dysphagia Among Stroke Survivors in Europe and North America

    Nov 1, 2011, 00:00

  • PHP113 Measuring the Organizational Performance in Tennessee- A Case of Community Hospitals

    Nov 1, 2011, 00:00

  • PDB64 Criteria for Referral of Type 2 Diabetes Patients from Primary Care to Specialized Care and Vice Versa in Spain. Pathways Study

    Nov 1, 2011, 00:00

  • PMD41 Drug Eluting Stent (DES) versus Bare Metal Stent (BMS) on Clinical, Humanistic and Economic outcomes- A 12-Month Prospective Observational Study

    Nov 1, 2011, 00:00

  • PSS18 Direct Economic Burden of Regular Intravitreal Injections for the Treatment of Retina Diseases in Three European Countries

    Nov 1, 2011, 00:00

  • PIH67 Successful Development of Annual and Long Term Prediction Models to Estimate Height Outcome following Growth Hormone (GH) Therapy in Children Using Data from KIGS – A Large Pharmacoepidemiological Survey

    Nov 1, 2011, 00:00

  • PHP154 Iranian Health System Decentralization Reform- A Qualitative Study of Various Levels of Autonomy Granted to Public Hospitals Affilieated with Ministry of Health in Iran

    Nov 1, 2011, 00:00

  • PMS62 Improved Fatigue and Physical Function are Correlated with Health-Related Quality of Life in Psoriatic Arthritis Subjects Treated with Apremilast- Results from a Phase 2, Randomized, Controlled Study

    Nov 1, 2011, 00:00

  • PSS43 A Systematic Review of Observational Studies of Patients With Ocular Hypertension or Glaucoma Receiving Long Term Topical Eye Therapies

    Nov 1, 2011, 00:00

  • PCV146 How Have Quality Checklists Improved the Quality of Published Economic Evaluations? An Example of Venous Thromboembolism (VTE) prophylaxis

    Nov 1, 2011, 00:00

  • PIN89 Do Patients and Physicians Have Similar Preferences Chronic Hepatitis B Treatment Outcomes in Turkey?

    Nov 1, 2011, 00:00

  • PSY11 Evaluacion Economica Del Uso Profilactico De Pegfilgastrim En Pacientes Con Quimioterapia Miloablativa Para Evitar La Neutropenia Febril

    Nov 1, 2011, 00:00

  • PMH11 Psychotropic-Related Hip Fractures Around the World- A Meta-Analysis

    Nov 1, 2011, 00:00

  • PCN188 Did Decision-Making Models from National Guidelines Change 1st Line Treatment Strategy for Patients with Metastatic Colorectal Cancer (MCRC)? The Results of Large Population Based Survey in Germany 2009

    Nov 1, 2011, 00:00

  • PDB3 Prevalence of Severe Osteoporosis in Daily Consultation of Rheumatology and Endocrinology Services, Costs and Quality of Life of Fragility Fractures in Mexico

    Nov 1, 2011, 00:00

  • PHP116 Clincal and Economic Evidence Bases for Health Technology Assessment- A Comparison of Three Jurisdictions

    Nov 1, 2011, 00:00

  • PCV63 Direct Health Care Costs of Oral Anticoagulant Treatment in Patients with Non Valvular Atrial Fibrillation

    Nov 1, 2011, 00:00

  • PHP126 Overview of HTA Process and Implementation Among Health Stakeholders in Bosnia and Herzegovina – Survey Based Research

    Nov 1, 2011, 00:00

  • PCV123 The Participation Decision for Lifestyle Disease Screening

    Nov 1, 2011, 00:00

  • CV3 Análisis De Costo Efectividad En El Cierre De La Comunicación Interatrial Ostium Secundum- Técnica Percutánea Versus Quirúrgica

    Nov 1, 2011, 00:00

  • PRS4 Effectiveness Of a Multifactorial Intervention to Improve Adherence in Patients with Chronic Obstructive Pulmonary Disease (COPD) Icepoc Study

    Nov 1, 2011, 00:00

  • PCN110 Economic Evaluation of Gefitinib for First-Line Treatment of EGFR Mutation Positive Advanced Non-Small Cell Lung Cancer Patients in Greece

    Nov 1, 2011, 00:00

  • PRS32 Cost-Effectiveness of Omalizumab in Severe Uncontrolled Allergic Asthma Using Rct and Real-World Evidence in the Dutch Setting

    Nov 1, 2011, 00:00

  • PRM64 The Role of the Instrument Developer in the Translation of Patient Reported Outcome Measures

    Nov 1, 2011, 00:00

  • PHP40 Promoting Efficiency of Available Capacity in A Fragmented Health System- Patients with Different Health Insurance Schemes Attended by Moh, Mexico 2006-2010

    Nov 1, 2011, 00:00

  • PHP13 Geographical Inequalities of Home Care (Nursing) in Hungary

    Nov 1, 2011, 00:00
  • «
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128 (current)
  • 129
  • 130
  • »